BASIC// DISCOVERY

STEM CELLS as a
PATHWAY to NEURO
REGENERATION

BIOSCIENTISTS’ ABILITY TO CREATE INDUCED PLURIPOTENT
stem cells—which can be differentiated into many
kinds of cells has opened new pathways for
research and treatment of many medical conditions.
One of the most notable areas of advancement by
stem cell researchers at Jefferson is in treatment for
conditions affecting the central nervous system.
For more than 20 years, Lorraine Iacovitti, PhD,
professor of neuroscience, neurology and
neurological surgery, has been making major
research contributions in stem cell biology
and the use of induced pluripotent stem cells
(iPSCs) to pursue therapies for stroke and
neurodegenerative disease. Her breakthrough
discovery for prompting stem cells to differentiate
into dopamine neurons has overcome a major
obstacle to using iPSCs therapeutically. More
recently, in studying an animal model of stroke,
she discovered the existence of stem cell niches
in the brain, which means that new cells can be
created throughout the adult brain. That work also
showed a dramatic surge in stem cell proliferation
and differentiation due to molecular and cellular
changes in the blood-brain-barrier after stroke.
Her lab is now pursuing opportunities to leverage
these changes to deliver stem cell therapeutics.
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Recently, Dr. Iacovitti has also identified distinct roles
in Parkinson’s disease played by nervous system
cells called astrocytes. Parkinson’s is characterized
by degeneration of dopamine neurons in the
substantia nigra region of the brain, while those of
the neighboring ventral tegmental area (VTA) are
relatively spared. In comparing the two regions,
Dr. Iacovitti found that astrocytes in the VTA
produce growth factor GDF-15, which can protect
dopamine neurons from the disease. The findings
suggest that microenvironments in the brain may
play a significant role in neurons’ susceptibility to
neurodegenerative disease—and they raise the
tantalizing possibility of a new Parkinson’s therapy
using patient-specific iPSC-derived VTA astrocytes.
Iacovitti’s colleague, Angelo Lepore, PhD, associate
professor of neuroscience, is also using iPSC-derived
astrocytes, but for a different purpose: to study
cellular mechanisms underlying traumatic spinal
cord injury (SCI). He is particularly interested in
understanding SCI-related respiratory dysfunction and
chronic neuropathic pain; and he hopes to develop
stem cell-based therapies that both address the
primary injury and protect neurons during the period
of secondary damage that patients experience.
Toward that end, Dr. Lepore is working on several
research paths involving astrocytes: identifying
molecules that inhibit or promote regeneration of
the axons that extend from nerve cells; uncover
astrocytes’ role in maintaining normal nervous system
function; and to pinpoint how alterations in synapse
signaling contribute to SCI disease processes.
It is known that, after SCI, astrocytes often lose the
capacity to properly regulate glutamate in neuronal
synapses, which contributes to further neurological
damage. Dr. Lepore’s lab has demonstrated that
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transplanting iPSC-derived astrocyte progenitor
cells can help protect respiratory function in animal
models of SCI. Now they are doing the fundamental
work necessary to demonstrate the potential of using
patient-specific iPSC-derived astrocyte progenitor
cells therapeutically.
Astrocytes also naturally promote growth of axons,
which are long fibers that extend from neurons
to convey electrical signals to other neurons and
muscles—a significant fact, given that axons do
not regenerate after central nervous system injury.
Dr. Lepore and his colleagues are engaged in a
long-term NIH-funded study of the role astrocytes
might play in promoting of axon regeneration
and sprouting to recovery of respiratory function

following SCI. Thus far, using a rat model of SCI,
the researchers have demonstrated that astrocyte
stem cells transplanted at spinal injury sites promote
robust axon growth and significant restoration of
diaphragm function—by prompting regenerating
axons to reconnect the neural circuit between brain,
spine and diaphragm that regulates breathing. They
have also found that astrocytes significantly dampen
the pro-inflammatory response that promotes
secondary damage. In their continuing work, they
are selectively silencing defined neuronal populations
involved in respiratory control, in order to understand
which kinds of axon growth actually promote
recovery of diaphragm function—information that
will be essential to develop new therapies. 
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